Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amdoxovir and Zidovudine in Untreated HIV-1 Infection
NCT00432016Phase 2Completed
- Sponsor
- RFS Pharma
- Start
- Feb 2007
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of amdoxovir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by RFS Pharma. Started Feb 2007; status: completed.
02
Drugs
amdoxovir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00432016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432016.